morphine sulphate / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 7 Diseases   379 Trials   379 Trials   12426 News 


«12...177178179180181182183184185186187...216217»
  • ||||||||||  morphine sulphate / Generic mfg., ropivacaine / Generic mfg.
    Trial completion date, Trial termination, Surgery:  EPICOL: Epidural Versus Patient-controlled Analgesia for Reduction in Long-term Mortality Following Colorectal Cancer Surgery (clinicaltrials.gov) -  Feb 16, 2021   
    P3,  N=221, Terminated, 
    Not yet recruiting --> Recruiting | Trial completion date: Sep 2021 --> Sep 2022 | Initiation date: Jul 2020 --> Dec 2020 | Trial primary completion date: Jan 2021 --> Jan 2022 Trial completion date: Dec 2021 --> Jan 2021 | Recruiting --> Terminated; Difficulty in recruiting
  • ||||||||||  morphine sulphate / Generic mfg., hydromorphone hydrochloride / Generic mfg.
    New P4 trial:  Intrathecal Opioids for Colorectal Resection (clinicaltrials.gov) -  Feb 12, 2021   
    P4,  N=85, Recruiting, 
  • ||||||||||  Fetroja (cefiderocol) / Shionogi
    Journal:  Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. (Pubmed Central) -  Feb 3, 2021   
    Similarly, the 5% dextrose admixtures of either ciprofloxacin or polymyxin B sulfate with 2% cefiderocol were incompatible, whereas data for phenylephrine hydrochloride morphine sulfate, or undiluted sodium bicarbonate were inconclusive. Overall, the 2% cefiderocol solution was physically compatible with 63 of 91 drugs challenged at 1:1 volume ratio in both 0.9% sodium chloride and 5% dextrose diluents for at least 4 hours at the concentrations tested in this study.
  • ||||||||||  morphine sulphate / Generic mfg.
    Enrollment open, Trial completion date, Trial primary completion date:  NOWSHINE: CHF6563 in Babies With Neonatal Opioid Withdrawal Syndrome (clinicaltrials.gov) -  Feb 2, 2021   
    P2,  N=99, Recruiting, 
    Overall, the 2% cefiderocol solution was physically compatible with 63 of 91 drugs challenged at 1:1 volume ratio in both 0.9% sodium chloride and 5% dextrose diluents for at least 4 hours at the concentrations tested in this study. Active, not recruiting --> Recruiting | Trial completion date: Jan 2021 --> Jan 2024 | Trial primary completion date: Nov 2020 --> Sep 2023
  • ||||||||||  Penthrox (methoxyflurane) / Medical Developments International
    Trial completion date, Trial primary completion date:  METHANE: Influence of METHoxyflurane on ANtiplatelet Effect of Ticagrelor in Patients With Unstable Angina Pectoris (clinicaltrials.gov) -  Feb 1, 2021   
    P4,  N=75, Recruiting, 
    Active, not recruiting --> Recruiting | Trial completion date: Jan 2021 --> Jan 2024 | Trial primary completion date: Nov 2020 --> Sep 2023 Trial completion date: Dec 2020 --> Dec 2021 | Trial primary completion date: Sep 2020 --> Sep 2021
  • ||||||||||  methadone / Generic mfg.
    Enrollment change:  Methadone in Neuropathic Pain (clinicaltrials.gov) -  Jan 28, 2021   
    P4,  N=14, Terminated, 
    Trial completion date: Dec 2020 --> Dec 2021 | Trial primary completion date: Sep 2020 --> Sep 2021 N=21 --> 14
  • ||||||||||  morphine sulphate / Generic mfg.
    Trial completion date, Trial primary completion date:  Sensory Effects of Oral Opioid Treatment in Patients With Chronic Low Back Pain (clinicaltrials.gov) -  Jan 28, 2021   
    P1,  N=100, Recruiting, 
    N=21 --> 14 Trial completion date: Sep 2020 --> Sep 2021 | Trial primary completion date: Sep 2020 --> Sep 2021
  • ||||||||||  morphine sulphate / Generic mfg.
    Trial completion date, Trial primary completion date:  Nalbuphine Versus Morphine for Mucositis Pain in Pediatric Cancer Patients (clinicaltrials.gov) -  Jan 27, 2021   
    P3,  N=110, Recruiting, 
    Trial completion date: Sep 2020 --> Sep 2021 | Trial primary completion date: Sep 2020 --> Sep 2021 Trial completion date: Dec 2020 --> Aug 2021 | Trial primary completion date: Dec 2020 --> Jun 2021
  • ||||||||||  morphine sulphate / Generic mfg.
    Trial completion date, Trial primary completion date:  2 Dose Neuraxial Morphine for Prevention of PDPH (clinicaltrials.gov) -  Jan 27, 2021   
    P4,  N=400, Recruiting, 
    Active, not recruiting --> Completed Trial completion date: Jun 2021 --> Jun 2023 | Trial primary completion date: Jun 2021 --> Jun 2023
  • ||||||||||  morphine sulphate / Generic mfg.
    Trial completion date:  Effect of Intrathecal Morphine on Chronic Pain After Elective Caesarean Section (clinicaltrials.gov) -  Jan 27, 2021   
    P4,  N=290, Active, not recruiting, 
    Trial completion date: Jun 2021 --> Jun 2023 | Trial primary completion date: Jun 2021 --> Jun 2023 Trial completion date: Dec 2020 --> Mar 2021
  • ||||||||||  morphine sulphate / Generic mfg., paracetamol / Generic mfg.
    Trial completion date, Trial primary completion date:  Postoperative Pain, Recovery and Discharge Following Robot-assisted Laparoscopic Prostatectomy (clinicaltrials.gov) -  Jan 26, 2021   
    P3,  N=180, Recruiting, 
    Trial completion date: Sep 2020 --> Sep 2022 | Trial primary completion date: Sep 2020 --> Sep 2022 Trial completion date: Sep 2021 --> Dec 2022 | Trial primary completion date: Dec 2020 --> Dec 2022
  • ||||||||||  morphine sulphate / Generic mfg.
    Trial completion, Enrollment change, Trial completion date, Trial primary completion date, Surgery:  Trial Comparing Intrathecal Morphine With Placebo In Patients Undergoing Robotic Cardiac Surgery (clinicaltrials.gov) -  Jan 25, 2021   
    P4,  N=79, Completed, 
    Trial completion date: Sep 2021 --> Dec 2022 | Trial primary completion date: Dec 2020 --> Dec 2022 Recruiting --> Completed | N=120 --> 79 | Trial completion date: Oct 2021 --> Sep 2020 | Trial primary completion date: Aug 2021 --> Sep 2020
  • ||||||||||  morphine sulphate / Generic mfg.
    [VIRTUAL] URINARY INCONTINENCE IN CHRONIC COUGH AND RESPONSES TO TREATMENTS () -  Jan 23, 2021 - Abstract #BTSWM2021BTS_WM_396;    
    Conclusions Different Interventions for chronic cough may have different impacts upon associated complications such as urinary incontinence. Furthermore specific intervention for urinary incontinence may be independently beneficial in this patient group.
  • ||||||||||  dexmedetomidine / Generic mfg.
    Trial completion, Enrollment change, Surgery:  Impact of Dexmedetomidine on Sleep Quality (clinicaltrials.gov) -  Jan 20, 2021   
    P4,  N=118, Completed, 
    Trial completion date: Dec 2020 --> Mar 2021 Recruiting --> Completed | N=76 --> 118
  • ||||||||||  morphine sulphate / Generic mfg.
    Trial completion, Trial completion date, Trial primary completion date:  Open Radical Prostatectomy and Erector Spinae Plane Block (clinicaltrials.gov) -  Jan 20, 2021   
    P=N/A,  N=50, Completed, 
    N=80 --> 40 Recruiting --> Completed | Trial completion date: May 2022 --> Jan 2021 | Trial primary completion date: May 2021 --> Jan 2021
  • ||||||||||  ketamine / Generic mfg.
    Trial completion date, Trial suspension, Trial primary completion date:  Intravenous Ketamine for Pain Control During First Trimester Surgical Abortion (clinicaltrials.gov) -  Jan 19, 2021   
    P3,  N=123, Suspended, 
    Recruiting --> Completed | Trial completion date: May 2022 --> Jan 2021 | Trial primary completion date: May 2021 --> Jan 2021 Recruiting --> Suspended | Trial primary completion date: Nov 2020 --> Dec 2021 | Trial completion date: Dec 2020 --> Dec 2021
  • ||||||||||  morphine sulphate / Generic mfg.
    Enrollment open:  Low Dose Morphine to Relieve Dyspnea in Acute Respiratory Failure (OPIDYS) (clinicaltrials.gov) -  Jan 18, 2021   
    P2,  N=22, Recruiting, 
    Recruiting --> Suspended | Trial primary completion date: Nov 2020 --> Dec 2021 | Trial completion date: Dec 2020 --> Dec 2021 Not yet recruiting --> Recruiting
  • ||||||||||  Chirocaine (levobupivacaine) / Purdue, AbbVie
    Trial completion date, Trial primary completion date:  DEPTHip: Delirium in Elderly Patients With Trauma of the Hip (clinicaltrials.gov) -  Jan 15, 2021   
    P4,  N=340, Recruiting, 
    Not yet recruiting --> Recruiting Trial completion date: Apr 2022 --> May 2023 | Trial primary completion date: Dec 2021 --> Dec 2022
  • ||||||||||  morphine sulphate / Generic mfg., ropivacaine / Generic mfg.
    Trial completion, Surgery:  TQL-block for Laparoscopic Hemicolectomy (clinicaltrials.gov) -  Jan 15, 2021   
    P4,  N=69, Completed, 
    Trial completion date: Apr 2022 --> May 2023 | Trial primary completion date: Dec 2021 --> Dec 2022 Recruiting --> Completed
  • ||||||||||  morphine sulphate / Generic mfg.
    Trial completion date, Trial primary completion date:  Sequential and Mixture Injection of Opioids and Hyperbaric Bupivacaine (clinicaltrials.gov) -  Jan 11, 2021   
    P4,  N=126, Recruiting, 
    Trial completion date: Dec 2020 --> May 2021 Trial completion date: Dec 2020 --> Mar 2021 | Trial primary completion date: Dec 2020 --> Mar 2021
  • ||||||||||  Trial completion date, Trial primary completion date:  Post-Op Pain Control for Prophylactic Intramedullary Nailing. (clinicaltrials.gov) -  Jan 8, 2021   
    P3,  N=60, Recruiting, 
    Trial completion date: Dec 2020 --> Mar 2021 | Trial primary completion date: Dec 2020 --> Mar 2021 Trial completion date: Oct 2021 --> Oct 2023 | Trial primary completion date: Aug 2021 --> Aug 2023
  • ||||||||||  Trial completion date, Trial initiation date, Trial primary completion date:  Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data (clinicaltrials.gov) -  Jan 7, 2021   
    P3,  N=35485, Not yet recruiting, 
    Trial completion date: Oct 2021 --> Oct 2023 | Trial primary completion date: Aug 2021 --> Aug 2023 Trial completion date: Jan 2025 --> Apr 2025 | Initiation date: Jan 2021 --> Apr 2021 | Trial primary completion date: Jan 2024 --> Apr 2024
  • ||||||||||  morphine sulphate / Generic mfg., ketamine / Generic mfg.
    Trial completion date, Trial primary completion date:  Postpartum Perineal Pain After Obstetric Anal Sphincter Injuries (clinicaltrials.gov) -  Jan 6, 2021   
    P4,  N=160, Recruiting, 
    Trial completion date: Jan 2025 --> Apr 2025 | Initiation date: Jan 2021 --> Apr 2021 | Trial primary completion date: Jan 2024 --> Apr 2024 Trial completion date: Apr 2022 --> Apr 2023 | Trial primary completion date: Dec 2021 --> Dec 2022
  • ||||||||||  Instanyl (fentanyl) / Takeda
    Enrollment change, Trial termination, Head-to-Head:  FINDOL: Intranasal Fentanyl Versus Oral Morphine Sulfate in the Treatment of Pain in Pediatric Trauma (clinicaltrials.gov) -  Dec 31, 2020   
    P3,  N=22, Terminated, 
    Trial completion date: Dec 2020 --> Dec 2021 | Trial primary completion date: Jul 2020 --> Dec 2021 N=82 --> 22 | Recruiting --> Terminated; The new pain protocols imposed by the HAS make it difficult to include new patients in the study
  • ||||||||||  morphine sulphate / Generic mfg., oxycodone/acetaminophen / Generic mfg., paracetamol / Generic mfg.
    Trial completion:  Analgesic Efficacy of (MSIR)/Acetaminophen vs. Oxycodone/Acetaminophen (Percocet) (clinicaltrials.gov) -  Dec 31, 2020   
    P2,  N=80, Completed, 
    N=82 --> 22 | Recruiting --> Terminated; The new pain protocols imposed by the HAS make it difficult to include new patients in the study Recruiting --> Completed